Delivery Order SPE2DB22D2007-SPE2DB25FH8PX
Award Date
1/29/25
Potential Completion Date
2/20/25
Potential Value
$29K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,565.56, is for the delivery of ZEPZELCA 4 MG VIALS, a specialty medication. The contract has an ultimate completion date of February 12, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of ZEPZELCA 4 MG VIALS. The contract is a Firm Fixed Price type with a ceiling value of $9,025.76 and a period of performance through September 4, 2024. The contract was awarded on August 13, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor for this delivery order. This...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,655.40 firm fixed-price delivery order contract is for the provision of ZEPZELCA 4 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (ABDC) for the supply of ZEPZELCA 4 MG VIALS. The contract has a ceiling value of $18,051.52 and an ultimate completion date of August 7, 2024. This contract is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, will deliver the specified drug product to support military treatment facilities and other federal healthcare providers...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $95,655.40, is a delivery order for the supply of ZEPZELCA 4 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of February 5, 2025 and was awarded on January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYRURNdz09) was issued by the Defense Logistics Agency (DLA) for the delivery of Zepzelca 4 mg vials, a specialty pharmaceutical product. The $35,563.44 firm fixed-price delivery order has an ultimate completion date of August 21, 2023 and was awarded on July 31, 2023. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a federal delivery order contract (SPE2DB22D2206|SPE2DB24FKH14) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $9,025.76 firm fixed-price contract is for the supply of the pharmaceutical product ZEPZELCA 4 MG VIALS. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a...
This is a $9,025.76 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ZEPZELCA 4 MG VIALS medical products. The contract has an ultimate completion date of November 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for providing a wide range of medical commodities, including prescription drugs,...
This federal contract award, valued at $9,565.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPZELCA 4 MG VIALS, a pharmaceutical product, with a completion date of January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg vials of the cancer drug ZEPZELCA, with a ceiling value of $9,025.76 and an ultimate completion date of September 12, 2024. The contract is a firm fixed-price, delivery order type with no set-aside designation. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen has been awarded...